Human Trials of Cancer Drug PAC-1 Continue with New Investment

Date

05/01/16

Clinical trials of the anti-cancer agent PAC-1 are continuing to expand, thanks to a $7 million angel investment from an anonymous contributor who originally invested $4 million to help get the compound this far in the drug-approval pipeline.

The U.S. Food and Drug Administration also granted PAC-1 orphan drug status for the treatment of glioblastoma multiforme, a deadly brain cancer. This designation is meant to encourage development of drugs to treat rare diseases or conditions affecting a small subset of the population. Some steps in the approval process are aided or expedited for orphan drugs.

An estimated 12,120 new cases of glioblastoma are expected in the U.S. in 2016. The median survival with standard-of-care therapy is 14.6 months.

PAC-1 targets an enzyme, procaspase-3, which is elevated in cancer cells. When activated, this enzyme spurs cell death. The drug first showed promise in the treatment of pet dogs with spontaneously occurring cancers.

Phase I clinical trial of PAC-1 in human cancer patients began in 2015 and has so far involved about a dozen patients with a variety of late-stage cancers. The human trial is being conducted at the University of Illinois Cancer Center in Chicago and at the Sidney Kimmel Cancer Center at Johns Hopkins University. A Champaign-based company, Vanquish Oncology, is the regulatory sponsor for the research.

Phase I trials are meant to determine the maximum tolerable dose of a cancer agent and are not tests of a drug’s efficacy, said University of Illinois chemistry professor Paul Hergenrother, who discovered PAC-1’s anti-cancer properties more than a decade ago. He worked with U. of I. veterinary clinical medicine professor Dr. Timothy Fan to first test the drug in pet dogs with cancer.

“There have been no unexpected toxicities and the dose escalation is progressing well,” Hergenrother said of the human trials. “This new investment will enable us to provide more cancer patients with access to the drug as we move forward with the Phase I trials.”

Some of the preclinical studies – in cells, mice, rats and dogs – suggested that PAC-1 could aid in the treatment of glioblastoma, a disease for which there are few therapeutic options.

“We know that PAC-1 can be safely combined with curative intent radiation therapy and oral temozolomide in dogs with primarily glioma, or brain tumors,” said Fan, who has worked closely with veterinary neurologist Dr. Michael Podell and veterinary radiation oncologist Dr. Jayme Looper of the Chicago-based MedVet Medical and Cancer Centers for Pets to conduct clinical trials of the drug in pet dogs.

 “Surgical resection, radiation and temozolomide is the standard treatment regimen for glioblastoma,” Hergenrother said.

 A second component of the Phase I trial will test PAC-1 in combination with temozolomide in human glioblastoma patients whose tumors have returned after standard treatment, he said.

“We’ve been at this now for more than 10 years, and we’re excited to be able to continue down this road,” Hergenrother said. “It takes a lot of time, a lot of effort and a lot of money to do human clinical trials. So to have the means to expand access to PAC-1 from a dozen patients to, we hope, hundreds, is very exciting. That is what will allow us to get some definitive data on the drug.”

 “PAC-1 is one of only a few drug agents developed and tested in animals and in humans at a single institution,” said Dr. Arkadiusz Dudek, a physician and professor of hematology and oncology at the University of Illinois at Chicago who is directing the human clinical trials of the drug. “It is gratifying to see new funding to allow this work to continue.”

Excerpted from UIUC News Bureau article by Diana Yates

University of Illinois chemistry professor Paul Hergenrother, right, and veterinary clinical medicine professor Timothy Fan tested an anti-cancer compound in pet dogs that is now being used in human clinical trials.

Photo by L. Brian Stauffer

Related People

Directory

scheelinAlexander
Scheeline
bjmccallBenjamin
McCall
cmartn10Calgary
Martin
r-gennisRobert
Gennis
j-gerltJohn
Gerlt
sgranickSteve
Granick
mgruebelMartin
Gruebele
hergenroPaul
Hergenrother
huangRaven
Huang
mlkraftMary
Kraft
leckbandDeborah
Leckband
yi-luYi
Lu
martinisSusan
Martinis
snairSatish
Nair
eoldfielEric
Oldfield
rienstraChad
Rienstra
cmsCharles
Schroeder
zanZaida
Luthey-Schulten
sksScott
Silverman
s-sligarStephen
Sligar
zhao5Huimin
Zhao
mselfba2Michelle
Self-Ballard
pbraunPaul
Braun
mdburkeMartin
Burke
jeffchanJefferson
Chan
sdenmarkScott
Denmark
dlottDana
Dlott
foutAlison
Fout
agewirthAndrew
Gewirth
ggirolamGregory
Girolami
shs3Sharon
Hammes-Schiffer
sohirataSo
Hirata
kamihullKami
Hull
jainPrashant
Jain
jkatzeneJohn
Katzenellenbogen
nmakriNancy
Makri
douglasmDouglas
Mitchell
jsmooreJeffrey
Moore
murphycjCatherine
Murphy
r-nuzzoRalph
Nuzzo
dimerPhilip
Phillips
rauchfuzThomas
Rauchfuss
joaquinrJoaquín
Rodríguez-López
jrogersJohn
Rogers
sarlahDavid
Sarlah
kschweizKenneth
Schweizer
jsweedleJonathan
Sweedler
vddonkWilfred
van der Donk
renskeRenske
van der Veen
vuraweisJosh
Vura-Weis
mcwhite7M.
White
sczimmerSteven
Zimmerman
beakPeter
Beak
wklemperWalter
Klemperer
jdmcdonaJ.
McDonald
mvp11Michael
Pak
pogoreloTaras
Pogorelov
mshen233Mei
Shen
dewoonDavid
Woon
wboulangWilliam
Boulanger
rxbRohit
Bhargava
qchen20Qian
Chen
jianjuncJianjun
Cheng
hy66Hong
Yang
andinomaJosé
Andino Martinez
decosteDonald
DeCoste
thhuangTina
Huang
tjhummelThomas
Hummel
dkellDavid
Kell
doctorkMichael
Koerner
marvilleKelly
Marville
crrayChristian
Ray
tlbrownTheodore
Brown
rmcoatesRobert
Coates
thdjrThom
Dunning,
dykstraClifford
Dykstra
j-jonasJiri
Jonas
j-lisyJames
Lisy
shapleyJohn
Shapley
pshapleyPatricia
Shapley
awieckowAndrzej
Wieckowski
zumdahl2Steven
Zumdahl
ksuslickKenneth
Suslick
jlbearJodi
Bear
jcoxJenny
Cox
ealthausEllen
Althaus
staciryStaci
Ryan
sqdSean
Drummond
dmillsDouglas
Mills
sheeleySarah
Sheeley
jsmaddenJoseph
Madden
cknight4Connie
Knight
schulzeHeather
Schulze
slangleySamantha
Langley
ssmurrayStar
Murray
kbaumgarKeena
Finney
adkssnBeatrice
Adkisson
bmylerBeth
Myler
trabari1Katie
Trabaris
kewatsonKaren
Watson
strussTheresa
Struss
metclfKara
Metcalf
ljohnso2Lori
Johnson
jlwJamison
Lowe
jenruslJennifer
Russell
lchenoweLeslie
Chenoweth
jcfJonathan
Freiman
wdedoWolali
Dedo
ebielserElaina
Kutz
spinnerDavid
Spinner
plblumPatricia
Simpson
stevens2Chad
Stevens
lsagekarLori
Sage-Karlson
bertholdDeborah
Berthold
kecarlsoKathryn
Carlson
tlchen4Timothy
Chen
sdesmondSerenity
Desmond
angelaecAngela
Crawford
hsahmed3Hajira
Ahmed
kakinsKenye
Akins
asali3Arzeena
Ali
axelson2Jordan
Axelson
bai11Yugang
Bai
scbakerStephanie
Baker
duffin2Kevin
Duffin
duttadDebapriya
Dutta
pflotschPriscila
Falagan Lotsch
iflemingIan
Fleming
dgrayDanielle
Gray
thennes2Thomas
Hennessey
mhettingMary Jo
Hettinger
holdaNancy
Holda
holler2Jordan
Holler
aibarrAlejandro
Ibarra
kimshSung Hoon
Kim
kocherg2Nikolai
Kocherginsky
philipk2Philip
Kocheril
dlee106David
Lee
legare2Stephanie
Legare
alewandoAgnieszka
Lewandowska
qianliliQianli
Li
bdmccallBirgit
McCall
smccombiStuart
McCombie
jdm5Justin
McGlauchlen
egmooreEdwin
Moore
myerscouKathleen
Myerscough
snalla2Siva
Nalla
oraham2Aaron
Oraham
lah5LeeAnn
Pannebaker
poonawa2Maria
Poonawalla
rrollerR.
Roller
romanovaElena
Romanova
roubakhiStanislav
Rubakhin
vsfVictoria
Shepherd-Fortner
shvedalxAlexander
Shved
asoudaAlexander
Soudakov
ktsween2Kalee
Sweeney
sktarterSamantha
Tarter
aathoma2Andy
Thomas
kwilhelKaren
Wilhelmsen
wilkeyRandy
Wilkey
luxu3Lu
Xu
yuanyao4Yuan
Yao
silongSilong
Zhang
schlembaMary
Schlembach
emccarr2Elise
McCarren
cmercierChristen
Mercier
atimpermAaron
Timperman
niesShuming
Nie
hshanHee-Sun
Han
mmgMutha Merenna Nuwan Bhagya
Gunasekera